HEALTH 11/16/2021 vials labeled "smallpox" found

jward

passin' thru
FBI investigating vials labeled 'smallpox' found in lab near Philadelphia

Jana Winter
Jana Winter

·Investigative Correspondent
Tue., November 16, 2021, 6:31 p.m.·2 min read


A bottle of smallpox vaccine held by gloved fingers.

A bottle of smallpox vaccine is held by a doctor at CDC headquarters in Atlanta in 2003. (Tami Chappell/Reuters)
WASHINGTON — The FBI and the Centers for Disease Control and Prevention are investigating “questionable vials” labeled "smallpox" and found in a freezer last night at a Merck facility outside Philadelphia, according to an alert sent to Department of Homeland Security leadership on Tuesday night.

There were reportedly a total of 15 questionable vials, according to the unclassified "For Official Use Only" alert, a copy of which was obtained by Yahoo News. Five of the vials were labeled as “smallpox” and 10 were labeled as “vaccinia." The vials were secured immediately.

The discovery of the vials prompted a lockdown of the facility, which has since been lifted. The FBI and CDC launched investigations, which remain ongoing.
Smallpox, a disease caused by the variola virus, is considered so deadly that only two labs in the world are authorized to store samples of the virus, including one in Russia and the other at the CDC in Atlanta.
Three people in hazmat suits prepare to enter a building.

A hazmat team prepares to enter a building. (Douglas Graham/Roll Call/Getty Images)
Scientists have debated for years whether to destroy any remaining samples, citing the danger of a mishap that could unleash a disease that has been eradicated since the 1970s. Those in favor of keeping samples have argued they are needed to develop new vaccines in response to a new outbreak.
The majority of Americans are not vaccinated against smallpox, and those who were vaccinated would likely now have waning immunity.

The CDC will arrive on site tomorrow to take custody of the vials and transport them to another facility for testing, the alert notes. No personnel were reportedly exposed to the material.
DHS and FBI did not immediately respond to a request for comment.
Editors' note: This is a developing story. It will be updated as new information becomes available.
 

jward

passin' thru
Also coincidentally and in totally unrelated news. . .

SIGA Announces BARDA Exercise of Procurement Option Valued at $112.5 Million for Oral TPOXX®
SIGA Technologies Inc.

6-8 minutes


NEW YORK, Sept. 13, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced the exercise of a procurement option under its 75A50118C00019 (19C) contract with Biomedical Advanced Research and Development Authority (BARDA), part of the office of the Assistant Secretary for Preparedness and Response at the U.S. Department of Health and Human Services for the delivery of oral TPOXX® treatment courses valued at approximately $112.5 million to the U.S. government. Product deliveries in connection with the option exercise are targeted for 2021.
“This option exercise, in combination with international orders, highlights the global importance of smallpox preparedness,” said Phil Gomez, CEO of SIGA. “With the option exercised under the 19C BARDA contract, SIGA has received orders valued at a total of approximately $123 million for the year to date for the procurement of oral TPOXX®”.

ABOUT SIGA TECHNOLOGIES, INC. and TPOXX®
SIGA Technologies, Inc. is a commercial-stage pharmaceutical company focused on the health security market. Health security comprises countermeasures for biological, chemical, radiological and nuclear attacks (biodefense market), vaccines and therapies for emerging infectious diseases, and health preparedness. Our lead product is TPOXX®, also known as tecovirimat and ST-246®, an orally administered and IV formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. TPOXX® is a novel small-molecule drug and the U.S. government maintains a stockpile of TPOXX® for treatment of smallpox. Over the past decade, the U.S. government has procured, or has current orders for, approximately $705 million of TPOXX® for national preparedness. The oral formulation of TPOXX® was approved by the FDA for the treatment of smallpox in 2018. The full label is here: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fce826ab-4d6a-4139-a2ee-a304a913a253. For more information about SIGA, please visit www.siga.com.

About Smallpox1
Smallpox is a contagious, disfiguring and often deadly disease that has affected humans for thousands of years. Naturally occurring smallpox was eradicated worldwide by 1980, the result of an unprecedented global immunization campaign. Samples of smallpox virus have been kept for research purposes. This has led to concerns that smallpox could someday be used as a biological warfare agent. A vaccine can prevent smallpox, but the risk of the current vaccine's side effects is too high to justify routine vaccination for people at low risk of exposure to the smallpox virus.

COVID-19 Pandemic
The COVID-19 pandemic has caused significant societal and economic disruption. Such disruption, and the associated risks and costs, are expected to continue for an indeterminate period of time. Given the uncertain scale, scope, and current and future impact of the pandemic, the Company is regularly reviewing business and financial risks, and seeking coordination with its government partners with respect to the performance of current and future contract timing and execution. Additionally, the Company is coordinating closely with service providers and vendors, in particular contract manufacturing organizations that constitute our supply chain, with respect to actions and risks caused by the COVID-19 pandemic. Finally, the Company has proactively provided its employees with resources and other support to help ensure continued success in remote work settings as they navigate the current pandemic environment.

The COVID-19 pandemic has not adversely affected the liquidity position of the Company, nor is it currently expected to have a material adverse effect on the financial condition of the Company. The pandemic has and may continue to delay the timing of international contract awards for oral TPOXX® given the need of government officials to focus on meeting the demands of the current COVID-19 pandemic. Additionally, the pandemic could result in a slower pace of product deliveries if the pandemic results in shortages or delays in the receipt by the supply chain of raw materials and other essential items for manufacturing. Otherwise, the pandemic is not currently expected to have a material adverse effect on the short-term financial results of the Company, although the Company cannot provide assurances as to the ultimate impact of the pandemic upon the broader macro environment or the Company’s industry.

FORWARD-LOOKING STATEMENTS
This press release contains certain "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. Such forward-looking statements are subject to various known and unknown risks and uncertainties, and SIGA cautions you that any forward-looking information provided by or on behalf of SIGA is not a guarantee of future performance. More detailed information about SIGA and risk factors that may affect the realization of forward-looking statements, including the forward-looking statements in this press release, is set forth in SIGA's filings with the Securities and Exchange Commission, including SIGA's Annual Report on Form 10-K for the year ended December 31, 2020, and in other documents that SIGA has filed with the SEC. SIGA urges investors and security holders to read those documents free of charge at the SEC's web site at http://www.sec.gov. Interested parties may also obtain those documents free of charge from SIGA. Forward-looking statements are current only as of the date on which such statements were made, and except for our ongoing obligations under the United States of America federal securities laws, we undertake no obligation to update publicly any forward-looking statements whether as a result of new information, future events, or otherwise.

The information contained in this press release does not necessarily reflect the position or the policy of the Government and no official endorsement should be inferred.
Investor Contacts:
Laine Yonker, Edison Group
lyonker@edisongroup.com
Michael Crawford, Edison Group
mcrawford@edisongroup.com
1 Smallpox - Symptoms and causes
 

jward

passin' thru
I was half way to "convinced this would prove to be a hoax" till I read your comment
... now I'm back to watching the sky for signs of it's imminent fall :eek:
You're pooping around, bitching because you have to clean the storage room. You're obviously not the star of the TV show here. So you find vials marked smallpox.

Do you stash one carefully before you report the others?
 

helen

Panic Sex Lady
That's one vaccination I'm glad I didn't resist getting. And I have the cratered moon on my left arm to prove I'm vaxxed so they can't keep me out of my favorite restaurants over this one!
The vaccination does not protect for very long. Boosters every few years are required.

You have the scar, but you are not immune to smallpox. I'm sorry.

With the exception of Case 12 who had an exceptionally mild illness, it is apparent that spread of the disease to date has been primarily among individuals vaccinated at times far distant in the past. Of the three fatalities to date, one occurred in a person never vaccinated and the other two in persons vaccinated more than 50 years prior to exposure.

International Notes -- Quarantine Measures Smallpox -- Stockholm, Sweden, 1963
 

WildDaisy

God has a plan, Trust it!
That's one vaccination I'm glad I didn't resist getting. And I have the cratered moon on my left arm to prove I'm vaxxed so they can't keep me out of my favorite restaurants over this one!

Does you no good now. The last smallpox vaccine was given in 1971 (unless you are authorized for special doses). Protection lasts 3-5 years. It is long past that.
 

Marie

Veteran Member
Cowpox has been erroneously reported as not occurring in the United States. However a common condition is proving otherwise.

Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions

Bovine Papillomatosis Hiding a Zoonotic Infection: Epitheliotropic Viruses in Bovine Skin Lesions
Laura Gallina, Federica Savini, [...], and Davide Lelli

Abstract
We describe two cases of skin co-infections with epitheliotropic viruses, detected in two cattle during lumpy skin disease (LSD) surveillance in northern Italy. A diagnostic protocol including different molecular methods as well as negative staining electron microscopy was applied to detect the most common viral agents belonging to the family Papillomaviridae, Poxviridae and Herpesviridae which cause skin diseases in cattle. Two specimens were collected from cases clinically diagnosed as papillomatosis and pseudo-LSD. Both skin lesions were shown to harbor more than one viral species. This case report shows, for the first time, co-infection of zoonotic parapoxvirus with bovine papillomavirus and herpesvirus in skin lesions of cattle. In particular, the simultaneous presence of virions morphologically referable to parapoxvirus and papillomavirus confirms that the replication of both viruses in the same lesion can happen and the so-called papillomatosis can bear zoonotic viruses.

Keywords: bovine, parapoxvirus, papillomavirus, herpesvirus, skin, co-infection, zoonosis
Skin represents the main barrier between external, potentially aggressive agents and inner, more vulnerable structures and represents a complex system harboring various populations of micro-organisms known as skin microbiota. Hyperproliferative skin lesions affecting the tissue and mucosa of cattle can be caused by bovine papillomavirus (BPVs), non-enveloped double stranded DNA viruses belonging to the Papillomaviridae family. Despite the benign characteristics of the lesions, in some cases, bovine papillomatosis can dramatically reduce production performance when lesions are spread throughout the body, involving teats and udders. We have previously shown that the so-called “papillomatosis” can be the result of multiple infections with epitheliotropic viruses, including zoonotic poxviruses [1,2].

Poxvirus and papillomavirus have been simultaneously detected in the skin lesions of cattle [3,4], birds [5,6] and humans [7], suggesting that these viruses can complete a replication cycle in the same lesions.

Here we describe two further cases of skin co-infections with epitheliotropic viruses that have been detected during a surveillance program for the viral cutaneous diseases of cattle implemented in Italy following the onset of lumpy skin disease (LSD) in some eastern European countries.

A diagnostic protocol, specifically set up to detect the most common viral agents causing skin diseases in cattle, was applied to cutaneous lesions collected from cattle involved in clinical cases reported in northern Italy. Briefly, skin lesions were tested for the presence of BPVs, bovine herpesviruses, parapoxviruses, orthopoxviruses and capripoxviruses using different techniques, combining molecular methods [1,8,9,10,11,12,13,14] as well as negative staining electron microscopy (nsEM) [15]. In Table 1, the virological diagnostic methods used in the study are reported.

Table 1
Virological diagnostic methods used in the study.
The first clinical case (#7) was identified on February 2018 at the slaughterhouse in a 20 months-old Charolaise cow in which cutaneous proliferative lesions were observed (Figure 1) and pathological skin samples were collected. Anamnesis reported a story of similar lesions in cattle from the same farm; the lesions appeared periodically but especially during the period December 2017–April 2018.

Figure 1
Skin proliferative lesion typical of bovine papillomatosis identified in Charolaise breeding cow sample (#7) (A) papilloma on the head (B) neck and shoulder.
The second clinical case (#1616) was identified during an outbreak of pseudo-LSD in a Fresian dairy farm during summer 2018. The 100-day-old calf presented lumps, scattered circular areas of alopecia and surface crust formation on the back, neck, shoulders and head (Figure 2).

Figure 2
Skin lesion identified in a Fresian dairy farm sample (#1616). The animal presented lumps, (A) scattered circular areas of alopecia and surface crust formation on back, (B) neck, shoulders and head.
In both cases, nsEM, RCA isothermal amplification, PCRs and sequencing of the amplification products were performed on pathological skin samples in order to identify the most common pathogens associated with cattle skin lesions, as well as bovine papillomavirus’ unknown circular genomes.

In the samples from case (#7), nsEM identified the simultaneous presence of parapoxvirus mature virions and non-enveloped icosahedral particles morphologically referable to papillomavirus (Figure 3A).

Figure 3
Negative-staining electron microscopy of: (A) sample (#7) showing the presence of a virions morphologically related to parapoxvirus ▲ and papillomavirus
An external file that holds a picture, illustration, etc.
Object name is pathogens-09-00583-i001.jpg
; (B) sample (#1616) showing the presence of a virion morphologically related to herpesvirus. ...
RCA followed by digestion with BamHI, HindIII and KpnI revealed the presence of BPV-12 while sequencing of the PCR products showed a co-infection with a zoonotic parapoxvirus and another bovine papillomavirus. The sequence obtained by the PCR specific for parapoxvirus (GenBank accession number: MT68213) showed a 99.81% identity to bovine papular stomatitis virus (BPSV) (GenBank accession number: MK285566). The presence of a second papillomavirus co-infecting the skin lesion was confirmed by the sequences of the E5 open reading frame (ORF) (GenBank accession number: MT682132) and partial L1 ORF (GenBank accession number: MT682133), which showed 100% identity to BPV-1 (GenBank accession number: MF384289.1).

Previous reports have identified the co-existence of parapox and orthopoxvirus particles in skin lesions of cattle by EM [16]. In humans, the simultaneous infection with human papillomavirus and poxvirus has shown the epidermis and follicle as the target area of viral infection [17]. To our knowledge, this is the first time that parapoxvirus and papillomavirus particles have been simultaneously detected by nsEM. This finding suggests that the production of infectious viral particles as a consequence of papillomavirus and parapoxvirus replication can occur. The rare co-existence of epitheliotropic viruses within epidermal lesions can take place since different cellular compartments and target cells can be used for these viruses to exert their pathogenic role with no interference. Poxviruses are known to exert host response evasion through virulence genes expressing immunomodulatory factors that may enhance the survival of papillomavirus in dual infections as reported by Payne and collaborators [7].

In samples from case (#1616), nsEM showed the presence of herpesviral particles (Figure 3B) subsequently identified as BoHV2 by PCR and sequencing (GenBank accession number: MT682134).

However, the protocol used for diagnosis also included a pan-parapoxvirus PCR followed by Sanger sequencing that allowed us to detect the zoonotic pseudocowpoxvirus (PCPV) (Genbank accession number: MT682135). Genomic amplification did not allow us to identify any bovine papillomavirus (BPVs). This finding further proves that virus co-infections are also possible between herpes and parapoxviruses. The definitive PLSD diagnosis for sample (#1616) was based on nsEM and sequencing of BoHV2, but the detection of PCPV DNA cannot be ignored since parapoxvirus should always be included in differential diagnosis. The impossibility of identifying PCPV by electron microscopy can be the result of a low viral load. On the other hand, the presence of PCPV DNA in the pathological samples led us to speculate that the virus may use such lesions as reservoirs to spread and persist in the environment through the scab material produced by other epitheliotropic viruses.

Our study confirms that cattle skin lesions may host diverse viral agents including zoonotic poxviruses. This is particularly important considering that all the parapoxviruses are responsible for common occupational zoonoses and humans can be infected after direct contact with affected cattle or indirectly through a contaminated environment as viruses survive for long periods when protected by organic material.
 

Luddite

Veteran Member
Do you stash one carefully before you report the others?

Naw, you report it thinking the over-paid seldom-working dickheads will be in BIG trouble. You think heads will roll.
Little do you know that NOTHING will happen.

Helen, I feel sure you mean well. I'm not sure you're seeing the big picture here.
These vaccines are worth Billions. If we are to believe the reports, we had only 2, count-em TWO sources from which to be worried.

Why would we need a jab for this?

Either a natural excuse or negligence is required to precipitate the need for these jabs.

This is the best form of marketing.

Getting back to the hypothetical janitor: This person should Wonder if they're an unwitting accomplice to a billion dollar sham.

These are just my uneducated musings before my first cup of coffee.
 
Last edited:

TerriHaute

Hoosier Gardener
My antennae went way up when I saw this article this morning:


Monkeypox Infection Confirmed in Maryland Resident Who Recently Returned from Nigeria
By Cristina Laila
Published November 16, 2021 at 10:51pm

A monkeypox infection (same family as smallpox) was confirmed Tuesday in a Maryland resident who recently traveled to Nigeria.
“The Maryland Department of Health, in collaboration with the U.S. Centers for Disease Control and Prevention (CDC), today confirmed a single case of monkeypox virus infection in a Maryland resident who recently returned from Nigeria.” More ⬇️ @wjz pic.twitter.com/8NL42Mxhs1
— Mike Hellgren (@HellgrenWJZ) November 17, 2021
“Public health authorities have identified and continue to follow up with those who may have been in contact with the diagnosed individual,” Dr. Jinlene Chan, MDH deputy secretary for public health, said in a statement. “Our response in close coordination with (Centers for Disease Control and Prevention) officials demonstrates the importance of maintaining a strong public health infrastructure.”

Cases of human monkeypox infections are rare outside of central and western African countries.

WBALTV reported:
A single case of monkeypox virus infection was confirmed Tuesday in a Maryland resident who recently returned from Nigeria.

Maryland health officials said the has mild symptoms, is currently recovering in isolation and is not hospitalized.
MDH said Monkeypox is in the same family of viruses as smallpox but generally causes a milder infection. It can be spread between people through direct contact with skin lesions or body fluids, or contaminated materials such as clothing or linens. It can also be spread through large respiratory droplets which generally cannot travel more than a few feet, and prolonged face-to-face contact is required.

MDH said illness typically begins with flu-like symptoms and swelling of the lymph nodes, progressing to a widespread rash on the face and body. Most infections last two to four weeks. The individuals identified as having been potentially exposed to this case will be monitored for symptoms of monkeypox for 21 days after exposure, MDH said.
 

AddisonRose

On loan from Heaven
My antennae went way up when I saw this article this morning:


Monkeypox Infection Confirmed in Maryland Resident Who Recently Returned from Nigeria
By Cristina Laila
Published November 16, 2021 at 10:51pm

A monkeypox infection (same family as smallpox) was confirmed Tuesday in a Maryland resident who recently traveled to Nigeria.

“Public health authorities have identified and continue to follow up with those who may have been in contact with the diagnosed individual,” Dr. Jinlene Chan, MDH deputy secretary for public health, said in a statement. “Our response in close coordination with (Centers for Disease Control and Prevention) officials demonstrates the importance of maintaining a strong public health infrastructure.”

Cases of human monkeypox infections are rare outside of central and western African countries.

WBALTV reported:
Hmmm. Come to think of it, our Monkeypox person disappeared off the radar screen after deplaning.
 

hunybee

Veteran Member

PghPanther

Has No Life - Lives on TB

This crypto "Amish" character sounds just like when software manufactures warn against hackers and then they come out with an antivirus product.......he ought to remember how that game was played.

So now he has switched from software to people..............
 

TammyinWI

Talk is cheap
Planted FF. Bill Gates stated in a video I posted here, on two threads, about "the next pandemic..." He must be psychic! Maybe he or his son is the anti-christ.
 

meandk0610

Veteran Member
My antennae went way up when I saw this article this morning:


Monkeypox Infection Confirmed in Maryland Resident Who Recently Returned from Nigeria
By Cristina Laila
Published November 16, 2021 at 10:51pm

A monkeypox infection (same family as smallpox) was confirmed Tuesday in a Maryland resident who recently traveled to Nigeria.

“Public health authorities have identified and continue to follow up with those who may have been in contact with the diagnosed individual,” Dr. Jinlene Chan, MDH deputy secretary for public health, said in a statement. “Our response in close coordination with (Centers for Disease Control and Prevention) officials demonstrates the importance of maintaining a strong public health infrastructure.”

Cases of human monkeypox infections are rare outside of central and western African countries.

WBALTV reported:
Plus there was one a few months ago in Georgia (or Dallas, and they had a layover in Georgia?) as well as several cases in the UK over the past year. Not “bad” for a rare virus!
 

Thinwater

Firearms Manufacturer
I call BS on the "Smallpox" label.

I was VERY terrified about ten years ago when a woman that I knew who worked for a level 4 lab said they found decades old vials of variola virus in a freezer they were replacing.

They took it straight to the incinerator and made no report. I guess we would have known about it by now if it were going to be a problem.
 

catskinner

Veteran Member
Saw my doctor Monday and was surprised when he said, "You've had the smallpox vaccine, right?" I told him no. He said, "Yes you did, let me see your arm." I was unable to get it because of a medical issue and then they did away with it being required, so I never got it. He just shook his head.
He is well know for burning the mid-night oil doing research and reading, to keep up on the latest medical stuff. Makes me wonder what he has found out.
 

Valann

Contributing Member
Maybe it's the next disease to be unleashed. Very odd that there is that kind of investment in a treatment for a virus that was eradicated over 40 years ago.
 

WalknTrot

Veteran Member
Smallpox vaccine from the pic, or labeled smallpox or vaccinia in the article. Makes a difference, and again, not a very informative piece.

Guess I wouldn't freak too much even if it was live smallpox, though I doubt it. Obviously, it's been sitting there for a good long while without causing any problems, and well...think of that 5+ year old bag of mystery "something" people find on any given day in their home freezers. Happens the same way in a lab freezer. Nobody deep cleans them until they quit working, get replaced, or are under new management.
 

Macgyver

Has No Life - Lives on TB
Interesting because I don't believe that Merck facility even existed back when small pox was a thing.
Had this shown up in there Rahway NJ location I be less surprised. That site goes back to almost 1900.

It's kind of like that Cobalt source that happened to be lying around in an old Kodak building in Rochester NY.
They did not know they had it and the feds had no record of giving it to them.
 
Top